vimarsana.com
Home
Live Updates
GPN Vaccines Reports Positive Safety and Immunogenicity Data from its Phase 1 Trial of Gamma-PN : comparemela.com
GPN Vaccines Reports Positive Safety and Immunogenicity Data from its Phase 1 Trial of Gamma-PN
ADELAIDE, Australia, Jan. 4, 2024 /PRNewswire/ — GPN Vaccines Ltd, a clinical-stage biotechnology company developing a Streptococcus pneumoniae vaccine to prevent...
Related Keywords
Australia ,
Adelaide ,
South Australia ,
Australian ,
Paul Rolan ,
Tim Hirst ,
Innovation Fund ,
Vaccines Ltd ,
Australian Government Research ,
Chief Medical Officer ,
Chief Executive Officer ,
South Australian Government ,
comparemela.com © 2020. All Rights Reserved.